Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2020 Mar;25(3):e469-e476. doi: 10.1634/theoncologist.2019-0541. Epub 2019 Nov 20.

2.

Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry.

Kurajoh M, Fukumoto S, Murase T, Nakamura T, Ishihara T, Go H, Yamamoto K, Nakatani S, Tsuda A, Morioka T, Mori K, Imanishi Y, Inaba M, Emoto M.

Int J Endocrinol. 2019 Dec 30;2019:1762161. doi: 10.1155/2019/1762161. eCollection 2019.

3.

Association of sarcopenia with phase angle and body mass index in kidney transplant recipients.

Kosoku A, Uchida J, Nishide S, Kabei K, Shimada H, Iwai T, Maeda K, Hanayama Y, Ishihara T, Naganuma T, Takemoto Y, Nakatani T.

Sci Rep. 2020 Jan 14;10(1):266. doi: 10.1038/s41598-019-57195-z.

4.

Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.

Watanabe D, Fujii H, Yamada Y, Iihara H, Ishihara T, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Anticancer Res. 2020 Jan;40(1):299-304. doi: 10.21873/anticanres.13953.

PMID:
31892580
5.

Effects of Inotropes on the Mortality in Patients With Septic Shock.

Sato R, Ariyoshi N, Hasegawa D, Crossey E, Hamahata N, Ishihara T, Nasu M, Devendra G.

J Intensive Care Med. 2019 Dec 3:885066619892218. doi: 10.1177/0885066619892218. [Epub ahead of print]

PMID:
31793373
6.

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Fujii H, Matsuhashi N, Kitahora M, Takahashi T, Hirose C, Iihara H, Yamada Y, Watanabe D, Ishihara T, Suzuki A, Yoshida K.

Oncologist. 2019 Nov 20. pii: theoncologist.2019-0541. doi: 10.1634/theoncologist.2019-0541. [Epub ahead of print]

7.

A Visual Task Management Application for Acute Ischemic Stroke Care.

Matsumoto S, Koyama H, Nakahara I, Ishii A, Hatano T, Ohta T, Tanaka K, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Watanabe S, Kondo D, Tsujimoto A, Furuta K, Ishihara T, Hashimoto T, Koge J, Sonoda K, Torii T, Nakagaki H, Yamasaki R, Nagata I, Kira JI.

Front Neurol. 2019 Oct 30;10:1118. doi: 10.3389/fneur.2019.01118. eCollection 2019.

8.

Reply to: The need for comprehensive NIRS-measurement from on-scene treatment to post-ROSC phase.

Takegawa R, Shiozaki T, Ogawa Y, Hirose T, Mori N, Ohnishi M, Shimazu T, Ishihara T, Shintani A.

Resuscitation. 2019 Nov;144:193-194. doi: 10.1016/j.resuscitation.2019.09.001. Epub 2019 Sep 7. No abstract available.

PMID:
31505233
9.

Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.

Yamada Y, Ohno Y, Kato Y, Kobayashi R, Hayashi H, Miyahara S, Nakane K, Mizutani K, Yokoi S, Fujii H, Iihara H, Ishihara T, Deguchi T, Sugiyama T, Suzuki A.

Cancer Chemother Pharmacol. 2019 Nov;84(5):987-992. doi: 10.1007/s00280-019-03935-x. Epub 2019 Sep 3.

PMID:
31482225
10.

Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination.

Oda K, Okada H, Suzuki A, Tomita H, Kobayashi R, Sumi K, Suzuki K, Takada C, Ishihara T, Suzuki K, Kano S, Kondo K, Iwashita Y, Yano H, Zaikokuji R, Sampei S, Fukuta T, Kitagawa Y, Okamoto H, Watanabe T, Kawaguchi T, Kojima T, Deguchi F, Miyazaki N, Yamada N, Doi T, Yoshida T, Ushikoshi H, Yoshida S, Takemura G, Ogura S.

J Clin Med. 2019 Aug 27;8(9). pii: E1320. doi: 10.3390/jcm8091320.

11.

Natural kinetics of blood cells following major burn: Impact of early decreases in white blood cells and platelets as prognostic markers of mortality.

Osuka A, Ishihara T, Shimizu K, Shintani A, Ogura H, Ueyama M.

Burns. 2019 Dec;45(8):1901-1907. doi: 10.1016/j.burns.2019.07.014. Epub 2019 Aug 2.

PMID:
31383608
12.

Reply to: Comment on "Usefulness of cerebral rSO2 monitoring during CPR to predict the probability of return of spontaneous circulation".

Takegawa R, Shiozaki T, Ogawa Y, Hirose T, Mori N, Ohnishi M, Ishihara T, Shintani A, Shimazu T.

Resuscitation. 2019 Sep;142:195-196. doi: 10.1016/j.resuscitation.2019.06.288. Epub 2019 Jul 9. No abstract available.

PMID:
31299259
13.

Tumor Size Drives the Prognosis After Hepatic Resection of Solitary Hepatocellular Carcinoma Without Vascular Invasion.

Shinkawa H, Tanaka S, Takemura S, Ishihara T, Yamamoto K, Kubo S.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04273-2. [Epub ahead of print]

PMID:
31197685
14.

A Scoring System with High-Resolution Computed Tomography to Predict Drug-Associated Acute Respiratory Distress Syndrome: Development and Internal Validation.

Anan K, Ichikado K, Ishihara T, Shintani A, Kawamura K, Suga M, Sakagami T.

Sci Rep. 2019 Jun 13;9(1):8601. doi: 10.1038/s41598-019-45063-9.

15.

High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yamada Y, Fujii H, Ohata K, Kato-Hayashi H, Watanabe D, Ishihara T, Uemura S, Iwashita T, Imai H, Matsuhashi N, Takahashi T, Sugiyama T, Shimizu M, Yoshida K, Suzuki A.

Med Oncol. 2019 Jun 3;36(7):63. doi: 10.1007/s12032-019-1288-7.

PMID:
31161433
16.

Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry.

Kurajoh M, Fukumoto S, Emoto M, Murase T, Nakamura T, Ishihara T, Go H, Yamamoto K, Nakatani S, Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Inaba M.

Clin Chem Lab Med. 2019 May 14. pii: /j/cclm.ahead-of-print/cclm-2019-0199/cclm-2019-0199.xml. doi: 10.1515/cclm-2019-0199. [Epub ahead of print]

PMID:
31085741
17.

Usefulness of cerebral rSO2 monitoring during CPR to predict the probability of return of spontaneous circulation.

Takegawa R, Shiozaki T, Ogawa Y, Hirose T, Mori N, Ohnishi M, Ishihara T, Shintani A, Shimazu T.

Resuscitation. 2019 Jun;139:201-207. doi: 10.1016/j.resuscitation.2019.04.015. Epub 2019 Apr 18.

18.

Age-related changes in serum periostin level in allergic and non-allergic children.

Fujitani H, Kasuga S, Ishihara T, Higa Y, Fujikawa S, Ohta N, Ono J, Izuhara K, Shintaku H.

Allergol Int. 2019 Apr;68(2):285-286. doi: 10.1016/j.alit.2018.12.006. Epub 2019 Jan 31. No abstract available.

19.

ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.

Kosoku A, Uchida J, Nishide S, Kabei K, Shimada H, Iwai T, Kuwabara N, Maeda K, Naganuma T, Kumada N, Takemoto Y, Ishihara T, Shintani A, Nakatani T.

PLoS One. 2018 Dec 31;13(12):e0208638. doi: 10.1371/journal.pone.0208638. eCollection 2018.

20.

High Dose Prednisolone Lowers Plasma Glycated Albumin Levels Compared to Actual Glycemic Control: A Retrospective Observational Study.

Mizuno M, Iizuka K, Ishihara T, Fukaya S, Yoshida S, Takeda J.

Diabetes Ther. 2019 Feb;10(1):269-276. doi: 10.1007/s13300-018-0552-8. Epub 2018 Dec 13.

Supplemental Content

Loading ...
Support Center